Founded in Australia, ResMed is now a global manufacturer of products for the treatment of sleep disorders, particularly obstructive sleep apnea . ResMed employs about 2700 employees worldwide, it has direct operations in 18 countries and distribution in more than 50 countries. In the fiscal year 2007/2008 it achieved revenues of US$ 800 million. ResMed considers the OSA market as underpenetrated and recently joined a partnership with LifeScan, a Johnson & Johnson company to increase awareness for OSA amongst type 2 diabetes patients. ResMed was formed in 1989, its primary purpose was to... commercialise a device for treating obstructive sleep apnea with nasal continuous positive airway pressure . CPAP treatment was commercialised by Peter Farrell and Professor Colin Sullivan. The company grew organically and through several acquisitions of small companies active in ventilation.
more
| NYSE symbol: | RMD |
| Founded: | 1989 |
| Headquarters: | Poway, California |
| Annual revenue: | $920,740,000 |
| Net income: | $146,450,000 |
| Operating income: | $197,800,000 |
| Market cap: | $4,100,000,000 |
| Industries: | Medical Equipment and Supplies Manufacturing |